The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function

By sjmartinez • February 15, 2023

Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-González G, Membrives C, Díaz-Tocados JM, Martínez-Moreno JM, Torralbo AI, Herencia C, Rodríguez-Ortiz ME, López-Baltanás R, Richards WG, Felsenfeld A, Almadén Y, Martin-Malo A, Ureña J, Santamaría R, Soriano S, Rodríguez M, Muñoz-Castañeda JR. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220. PMID: 35867864; PMCID: PMC9923714.

Tags: arterial stiffness, Chronic kidney disease, FGF23, microRNA, Nephrology, Publications, vascular smooth muscle cells

Obesity and Cardio-Metabolic Health in Kidney Disease: Implications for Kidney Health, Risk Stratification, and Management

Mathew RO, Hong A, Narasaki Y, Fung E, Cheung D, Han J, Durstenfeld MS, Hsue PY, Rhee CM. Obesity and Cardio-Metabolic Health in Kidney Disease:[...]

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real-World Data: The INVESTED-Medicare Linkage Study

Cho H, Shin H, Najafzadeh M, Claggett B, Ortega-Montiel J, Liu J, Paik JM, Lalani NF, Bradley MC, Concato J, Solomon SD, Vardeny O, Patorno[...]

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Bea S, Patorno E, Sreedhara SK, Wexler DJ, Cromer SJ, Glynn RJ, Paik JM, Bykov K. Comparative Short-term Risk of Severe Gastrointestinal Events Associated With[...]